Clinical Trials Directory

Trials / Completed

CompletedNCT01454609

Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy

Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy - a Double Blind Randomized Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research · Other Government
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

With thyroid surgery being performed as an ambulatory procedure, most recent studies concerning post thyroidectomy analgesia are focused on regional techniques such as bilateral superficial cervical plexus block (BSCPB) and bilateral combined superficial and deep cervical plexus block. But, data regarding the efficacy of BSCPB are controversial. Hence the investigators compared the efficacy of BSCPB with 0.25% bupivacaine with or without clonidine in thyroidectomy, as preemptive analgesia. The hypothesis was bupivacaine with the addition of clonidine would help in reducing postoperative pain and thereby reduce the need for postoperative analgesia.

Detailed description

To find out if addition of BSCPB to general anesthesia with bupivacaine with or without clonidine prolongs the time needed for postoperative analgesic and facilitate to perform thyroidectomy as a day care procedure and to see if clonidine reduces postoperative nausea and vomiting.

Conditions

Interventions

TypeNameDescription
DRUG0.9% Normal salineSaline
DRUGBupivacaineBupivacaine - amide local anesthetic, maximum recommended dose is 2 mg/kg duration 2 - 4 hours of sensory anesthesia up to 24 hours
DEVICEBupivacaine with clonidine (combination)Bupivacaine - amide local anesthetic, maximum recommended dose is 2 mg/kg duration 2 - 4 hours of sensory anesthesia up to 24 hours Clonidine - 0.5 - 1 microgram/ kg

Timeline

Start date
2009-01-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2011-10-19
Last updated
2011-10-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01454609. Inclusion in this directory is not an endorsement.